Pheast Therapeutics has treated the first subject in a multi-centre Phase I trial for the anti-cluster of differentiation 24 (CD24) macrophage checkpoint blocker PHST001, aimed at treating advanced ...

Rosatom has completed research and development (R&D) on a technology for the processing of liquid radioactive sodium coolant, ...

Phase transitions and critical phenomena are ... A change in the state of matter, such as from a solid to a liquid, is a classic example. Ranking node importance in a network is a fundamental ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

Pyrovanadates are deemed as an ideal class of potential Calcium ion storage hosts, owing to abundant confined species. However, the higher Coulombic hinderance brings about more sluggish diffusion ...

Researchers from the Institute of Solid State Physics, the Hefei Institutes of Physical Science of the Chinese Academy of ...

On Tuesday, Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. The expansion will evaluate the combination of ...

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.